These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4020409)

  • 1. Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside.
    Griffin JD; Spriggs D; Wisch JS; Kufe DW
    J Clin Oncol; 1985 Jul; 3(7):982-91. PubMed ID: 4020409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of preleukemic syndromes to continuous infusion of low-dose cytarabine.
    Wisch JS; Griffin JD; Kufe DW
    N Engl J Med; 1983 Dec; 309(26):1599-602. PubMed ID: 6646185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of low-dose cytosine arabinoside.
    Spriggs D; Griffin J; Wisch J; Kufe D
    Blood; 1985 May; 65(5):1087-9. PubMed ID: 3995167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.
    Winter JN; Variakojis D; Gaynor ER; Larson RA; Miller KB
    Cancer; 1985 Aug; 56(3):443-9. PubMed ID: 3859362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.
    Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Browman G; Walker I; Grunwald H; D'Arrigo P; Stein A
    Am J Hematol; 1986 Oct; 23(2):131-4. PubMed ID: 3529939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia.
    Roberts JD; Ershler WB; Tindle BH; Stewart JA
    Cancer; 1985 Sep; 56(5):1001-5. PubMed ID: 3860278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion high-dose cytosine arabinoside in refractory childhood leukemia.
    Ochs J; Sinkule JA; Danks MK; Look AT; Bowman WP; Rivera G
    J Clin Oncol; 1984 Oct; 2(10):1092-7. PubMed ID: 6593435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
    Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
    J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes.
    Silverman LR; Holland JF; Weinberg RS; Alter BP; Davis RB; Ellison RR; Demakos EP; Cornell CJ; Carey RW; Schiffer C
    Leukemia; 1993 May; 7 Suppl 1():21-9. PubMed ID: 7683352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose cytosine arabinoside therapy in myelodysplastic syndrome and acute myeloid leukemia.
    Katayama N; Tanaka I; Minami N; Shirakawa S
    Jpn J Clin Oncol; 1987 Jun; 17(2):117-21. PubMed ID: 3475489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of myelodysplastic syndrome using continual subcutaneous infusion of low doses of cytosine arabinoside].
    Vozobulová V; Koza V; Cepelák V; Neuwirtová R; Masek Z
    Vnitr Lek; 1990 May; 36(5):483-8. PubMed ID: 2375080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and clonal culture evaluation after response to low dose Ara-C in myelodysplastic syndromes.
    Hotta T; Goto S; Tsushita K; Kagami Y; Ohashi H; Ichikawa A; Ichihara M; Takagi N; Murate T; Yamao H
    Leukemia; 1991 Nov; 5(11):962-6. PubMed ID: 1961037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP; Hirji K; Itri L
    Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-dose cytosine arabinoside treatment of leukemia with special reference to the optimal number of doses].
    Sampi K; Maseki N; Kumai R; Kaneko Y; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2595-8. PubMed ID: 2774589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C).
    Lin SF; Liu HW; Chen TP
    Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):45-50. PubMed ID: 2330805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of high-dose cytosine-arabinoside in the treatment of resistant acute leukemia].
    Witz F; Olive D; Lederlin P; Bordigoni P; Troussard X; Grosbois B; Schaison G; Cornu G
    Presse Med; 1987 Feb; 16(4):159-62. PubMed ID: 2950446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose cytosine arabinoside regimen induced a complete remission with normal karyotypes in a case with hypoplastic acute myeloid leukaemia with No. 8-trisomy: in vitro and in vivo evidence for normal haematopoietic recovery.
    Tagawa M; Shibata J; Tomonaga M; Amenomori T; Yoshida Y; Kuriyama K; Matsuo T; Sadamori N; Ichimaru M
    Br J Haematol; 1985 Jul; 60(3):449-55. PubMed ID: 3860248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromes.
    Hoelzer D; Ganser A; Schneider W; Heimpel H
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):208-11. PubMed ID: 4012339
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia.
    Stone RM; Spriggs DR; Dhawan RK; Arthur KA; Mayer RJ; Kufe DW
    Leukemia; 1990 Dec; 4(12):843-7. PubMed ID: 2243507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens.
    Zeremski V; Savić A
    Med Pregl; 2014; 67(3-4):83-90. PubMed ID: 24961049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.